#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary haemorrhagic telangiectasia Palmar-plantar erythrodysaesthesia syndrome Penile cancer Hyperadrenocorticism Type IIa hyperlipidaemia Facioscapulohumeral muscular dystrophy Enteritis Spinal cord injury Neurofibromatosis Indolent systemic mastocytosis Myelodysplastic syndrome with excess blasts Pleural mesothelioma malignant Pyruvate dehydrogenase complex deficiency Neuromyelitis optica spectrum disorder Pleural mesothelioma More trials…

    Learn about Rare Diseases

    Factor VIII deficiency – Basic Information Medulloblastoma Mast cell activation syndrome – Treatment Richter’s syndrome – Basic Information Pemphigus – Treatment Alport’s syndrome – Diagnostics Mantle cell lymphoma stage II – Trials in Disease Paraneoplastic neurological syndrome – Trials in Disease Mucopolysaccharidosis III – Diagnostics Haemophilia A without inhibitors – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Glenzocimab Pasireotide Efanesoctocog Alfa Pertuzumab Lufepirsen SC0062 Lanifibranor Gadoquatrane Ondansetron Efinopegdutide Eculizumab Imipenem Anhydrate Ly3437943 Sodium GSKVX000000048111 Ianalumab Sodium Fluoride (18F) BROLUCIZUMAB Abc-15Bo-116 Molidustat Sodium Sodium Glycerophosphate More therapies…

    Learn about Your Condition

    Renal impairment Adenovirus infection Carcinoid syndrome Neoplasm Venous thrombosis limb Breast cancer stage I Meningioma malignant Synovial sarcoma recurrent Rabies Thrombolysis Ovarian cancer stage III Overweight Congenital aplastic anaemia Adenocarcinoma pancreas Small intestine adenocarcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Therapeutics

  • Study on the Safety of Lutetium (177Lu) Zadavotide Guraxetan and Radium Ra 223 Dichloride for Patients with Bone-Metastatic Prostate Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    • Prostate cancer recurrent
    Investigated Drugs:
    • Lutetium (177Lu) Zadavotide Guraxetan
    • Radium Ra 223 Dichloride
    The Netherlands

  • Study on Ivabradine for Heart Rate Control and Survival in Adults with Septic Shock

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Septic shock
    Investigated Drugs:
    • Ivabradine Hydrochloride
    France

  • Study on Rituximab for Reducing Steroid Use in Newly Diagnosed Polymyalgia Rheumatica Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Polymyalgia rheumatica
    Investigated Drugs:
    • Rituximab
    The Netherlands

  • Study on Improving Treatment for Sickle Cell Disease Patients Using Hydroxycarbamide

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Sickle cell disease
    Investigated Drugs:
    • Hydroxycarbamide
    France

  • Study of Irinotecan with FOLFOX and Bevacizumab for Patients with Unresectable Colorectal Cancer Metastases

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastases to peritoneum
    • Colorectal cancer metastatic
    • Colorectal cancer
    Investigated Drugs:
    • Irinotecan Hydrochloride Trihydrate
    The Netherlands

  • Study on the Effects of Calcium, Tacrolimus, and Mycophenolate Mofetil in Patients with Kidney Transplants

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Calcium
    • Colecalciferol
    • Mycophenolate Mofetil
    Norway
Previous Page
1 … 18 19 20 21 22 … 24
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!